you missed my point you muppet - i was referring to the value of the announcement for retail investors, not the medical field. Of course the medical field cares, my point is the value of high performance results and the sheer volume of them has been diluted for retail investors, and you can see that for yourself when these come out, minimal increased volume on the market...compared to say 3 years ago. L
AVR results presentation at CRT 24 Washington DC 9th to 12th March, page-38
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.32 |
Change
-0.590(5.95%) |
Mkt cap ! $196.8M | |||
| Open | High | Low | Value | Volume |
| $9.50 | $9.61 | $9.30 | $132.4K | 13.99K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 177 | $9.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.84 | 1455 | 3 |
View Market Depth
| Last trade - 15.12pm 13/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |